FMR CORP 13D and 13G filings for Ionis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 09:16 am Purchase |
2024-02-08 | 13G | Ionis Pharmaceuticals, Inc. IONS |
FMR CORP | 21,520,872 15.000% |
213,353 (+1.00%) |
Filing |
| 2023-02-09 11:18 am Purchase |
2023-02-09 | 13G | Ionis Pharmaceuticals, Inc. IONS |
FMR CORP | 21,307,519 14.999% |
126,017 (+0.59%) |
Filing |
| 2022-02-09 09:19 am Purchase |
2022-02-08 | 13G | Ionis Pharmaceuticals, Inc. IONS |
FMR CORP | 21,181,502 14.999% |
201,780 (+0.96%) |
Filing |
| 2021-02-08 10:25 am Sale |
2021-02-05 | 13G | Ionis Pharmaceuticals, Inc. IONS |
FMR CORP | 20,979,722 14.999% |
-144,340 (-0.68%) |
Filing |